ArticleThe journal of prevention of Alzheimer's disease2026

Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.

Noelia Fandos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.